• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.

To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
Cardiac Structure and Function

Ancora Heart’s AccuCinch System Demonstrates Significant Improvement in Quality of Life

Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), announced that patients treated with the investigational AccuCinch® Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart. The 12-month data were presented as part of a late-breaking clinical science session at the Technology and Heart Failure Therapeutics conference (THT 2023) and simultaneously published in the Journal of Cardiac Failure.

Read more →
SIFT-MS, Syft Tracer TM

Syft Technologies Announces Next Generation SIFT-MS, Syft Tracer™

Syft Technologies today announced the release of its next generation Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) technology, Syft Tracer™, at Pittcon 2023. This innovation of real-time, direct injection mass spectrometry (MS) offers platform advancements such as greater sensitivity, unparalleled performance stability, and high reproducibility and repeatability that make the system an industry-scalable solution. Analytical workflows that require fast time to data, high throughput, and continuous operation will benefit significantly from Syft Tracer capabilities.

Read more →

The U.S. Food and Drug Administration has granted 510(k) clearance to SurgVision's Explorer Air® II

SurgVision, a high-tech company developing pioneering solutions for fluorescence-guided surgical and interventional oncology, part of the Bracco Group, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration for the EXPLORER AIR® II for use with Pafolacianine (CYTALUX, On Target Laboratories Inc.) during intraoperative fluorescence imaging.

Read more →
DeltaScan Brain State Monitor

DeltaScan® Brain State Monitor for Detecting Acute Encephalopathy

Prolira BV, a high-tech company committed to enabling early and effective treatment of patients at risk of developing acute brain failure, announced it has received 510(k) clearance from the Food and Drug Administration (FDA) for the DeltaScan® Brain State Monitor to aid in the diagnosis of acute encephalopathy in hospitalized patients over 60 years of age.

Read more →
Lithography Process Tool Monitoring System

Picarro's New 1-ppb Class Chemical Metrology Solution for Lithography

Picarro Inc., a leading provider of chemical metrology systems for advanced semiconductor fabs, announced the SLiM 100 Lithography Process Tool Monitoring System. The new 1-ppb class chemical metrology solution detects volatile organic compounds (VOCs) in the lithography process in real time, enabling semiconductor manufacturers to quickly take steps to prevent excursions and detect non-visual defects, thereby improving yield.

Read more →
CLIA Waiver

CLIA Waiver for Second Generation Sexual Health Test for Women

Visby Medical™ announced that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration for its second generation point of care (POC) test. The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.

Read more →
spine surgery at DISC Surgery Cente

DISC Surgery Center to Provide Greater Access to Outpatient Spine Care

DISC Surgery Center at Newport Beach ("DISC") has deepened its partnership with Blue Shield of California ("Blue Shield") to both advance and increase access to leading-edge spine care in the outpatient setting.Announcement is the result of a thoughtful and swift negotiation. DISC, through parent company TriasMD, was one of the first surgery centers in California to work directly with Blue Shield in 2023 to establish a new and expansive contract.

Read more →